These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7674268)

  • 21. [Prevention of target organ damage with modern antihypertensive agents].
    Páll D; Katona E; Juhász M; Paragh G
    Orv Hetil; 2006 Aug; 147(32):1505-11. PubMed ID: 16981424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fixed-dosage combinations in the treatment of hypertension].
    Muiño Miguez A; López Glez-Cobos C; Villalba García MV; Segado Soriano A; Granda Martín MJ; Gil Gómez J
    An Med Interna; 1999 Feb; 16(2):92-6. PubMed ID: 10193003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic principles and possible variations in combination antihypertensive therapy].
    Scholze J
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):155-63. PubMed ID: 9244658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update of diuretics in the treatment of hypertension.
    Padilla MC; Armas-Hernández MJ; Hernández RH; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):154-60. PubMed ID: 17414583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interactions between antihypertensive agents of different mechanisms of action].
    Hitzenberger G
    Wien Med Wochenschr; 1995; 145(15-16):352-4. PubMed ID: 7502513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision-making in the development of new drugs.
    Breckenridge A
    J Hypertens Suppl; 1985 Nov; 3(2):S51-5. PubMed ID: 3910776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic principles for combination therapy.
    Toews ML; Bylund DB
    Proc Am Thorac Soc; 2005; 2(4):282-9; discussion 290-1. PubMed ID: 16267349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.
    Lam YW; Shepherd AM
    Clin Pharmacokinet; 1990 Apr; 18(4):295-317. PubMed ID: 2182265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive drug interactions.
    Carter BL
    Drugs Today (Barc); 2005 Jan; 41(1):55-63. PubMed ID: 15753969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug interactions in hypertension.
    Wood AJ
    Hypertension; 1988 Mar; 11(3 Pt 2):II1-3. PubMed ID: 3280485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertaconazole induced toxicity in HeLa cells through mitotic arrest and inhibition of microtubule assembly.
    Sebastian J; Rathinasamy K
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1231-1249. PubMed ID: 33620548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current pharmaco-therapeutic strategies in the treatment of arterial hypertension].
    Beaufils M; Clément DL
    Drugs; 1998; 56 Suppl 2():11-21. PubMed ID: 9813738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic aspects of the choice of components of combination therapy.
    Reid JL
    J Hum Hypertens; 1995 Aug; 9 Suppl 4():S19-23. PubMed ID: 7674268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.